English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Background  The American Heart Association Get With the Guidelines ( GWTG ) program has improved care quality of acute myocardial infarction ( AMI ) with important implications for other countries in the world. This study evaluated the incidence and care of  AMI  in Taiwan and assessed the compliance of  GWTG  in Taiwan.    Methods and Results  We used the Taiwan National Health Insurance Research Database (1999–2008) to identify hospitalized patients ≥18 years of age presenting with  AMI . The temporal trends of annual incidence and care quality of  AMI  were evaluated. The age‐adjusted incidence of  AMI  (/100 000 person‐years) increased from 28.0 in 1999 to 44.4 in 2008 ( P <0.001). The use of guideline‐based medications for  AMI  was evaluated. The use of dual antiplatelet therapy ( DAPT ) increased from 65% in 2004 to 83.9% in 2008 ( P <0.001). Angiotensin‐converting enzyme ( ACE ) inhibitor or angiotensin receptor blocker ( ARB ) was used in 72.6% in 2004 and 71.7% in 2008 ( P = NS ) and β‐blocker was used in 60% in 2004 and 59.7% in 2008 ( P = NS ). Statin use increased from 32.1% to 50.1% from 2004 to 2008 ( P <0.001). The in‐hospital mortality decreased from 15.9% in 1999 to 12.3% in 2008 ( P <0.0001). Multivariable analysis showed that  DAPT ,  ACE  inhibitor/ ARB , β‐blocker, and statin use during hospitalization were all associated with reduced in‐hospital mortality in our  AMI  patients.    Conclusions   AMI  incidence was increasing, but the guideline‐based medications for  AMI  were underutilized in Taiwan. Quality improvement programs, such as  GWTG , should be promoted to improve  AMI  care and outcomes in Taiwan.

Trends in the Incidence and Management of Acute Myocardial Infarction From 1999 to 2008: Get With the Guidelines Performance Measures in Taiwan